1. Home
  2. WLTH vs BHVN Comparison

WLTH vs BHVN Comparison

Compare WLTH & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WLTH

Wealthfront Corporation Common Stock

N/A

Current Price

$8.44

Market Cap

1.7B

Sector

Finance

ML Signal

N/A

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$13.55

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLTH
BHVN
Founded
2008
2013
Country
United States
United States
Employees
391
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
WLTH
BHVN
Price
$8.44
$13.55
Analyst Decision
Buy
Buy
Analyst Count
8
14
Target Price
$12.86
$29.08
AVG Volume (30 Days)
2.1M
3.2M
Earning Date
05-18-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.08
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.58
N/A
Revenue Next Year
$23.43
N/A
P/E Ratio
$10.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.20
$7.48
52 Week High
$14.12
$18.57

Technical Indicators

Market Signals
Indicator
WLTH
BHVN
Relative Strength Index (RSI) 28.40 70.40
Support Level $8.29 $13.41
Resistance Level $9.32 $15.71
Average True Range (ATR) 0.62 0.91
MACD -0.26 0.26
Stochastic Oscillator 8.61 84.29

Price Performance

Historical Comparison
WLTH
BHVN

About WLTH Wealthfront Corporation Common Stock

Wealthfront Corp is a product-driven technology company that built a financial solutions platform for digital natives. The platform is designed to address the needs of the wealth builders within these generations. Its business model is designed to optimize for clients' success. The focus on delivering fully automated services results in being one of the lowest cost producers in each category in which participate. The group generates revenue from cash management and investment advisory products. Cash management revenue is earned from fees received for the delivery of cash management services, including the cash sweep program.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: